Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 17: AMD IV Session

Date/Time: | Room:

Back to Previous



14:30:00 R. Tadayoni France Comparative assessment of retinal fluid in patients treated with brolucizumab and aflibercept: 36–48 Week data from HAWK and HARRIER
14:36:00 A. Cusumano Italy Shortterm assessment of retinal function following 2RT laser treatment for intermediate AMD: a pilot study including electrophysiology
14:42:00 S. Bolme Norway Comparison of physician and nurseadministered intravitreal injections of antivascular endothelial growth factor, a randomized noninferiority trial
14:48:00 F. Holz Germany Treatment patterns in prior ranibizumabtreated patients with neovascular agerelated macular degeneration: realworld outcomes from the LUMINOUS study
14:54:00 M. Pfau Germany Patient tailored perimetry in geographic atrophy secondary to agerelated macular degeneration: probing of cone and rodfunction in the junctional zone with highspatial resolution
15:00:00 S. Kadayifcilar Turkey Evaluation of the frequency of complement factor I gene polymorphism in a Turkish age related macular degeneration population
15:06:00 A. Wolf Germany Dynamics of systemic free VEGFA in AMD patients during antiVEGF treatment with ranibizumab versus aflibercept
15:12:00 M. Zinkernagel Switzerland Following excitement and anxiety response under intravitreal injection: The FEAR study
15:18:00 J. Monés Spain The q12w dosing status with brolucizumab in patients with neovascular agerelated macular degeneration and the impact of baseline characteristics: Results from the Phase III HAWK and HARRIER trials
15:24:00 R. Guymer Australia Subthreshold nanosecond laser intervention to slow progression in intermediate agerelated macular degeneration
15:30:00 S. Moradian Iran, Islamic Republic of A population based study on the prevalence and risk factors of agerelated macular degeneration in Northern Iran The Gilan Eye Study
15:36:00 H. Gerding Switzerland Tenyear outcome of antiVEGF treatment in patients with agerelated macular degeneration
15:42:00 V. Capuano France Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks
15:48:00 K. Biswas India Prevalence of age related macular degeneration (AMD) in high altitude Himalayan population

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved